. The Company has drawdown loan for acquisition of subsidiary shares in 2Q’18 causing rising debt level at the end of December 2018 and subsequently paid down loan from its operating cash flow and
53.7 Debt Service Coverage 673.5 10.1 Total Debt to Equity 0.2 0.3 * calculated by using earnings of current quarter to be estimated for annual earnings ** based on only cost of medicine & medical
factsheet) โดยมีอตัราสว่นท่ีมีนยัส าคญั ทางการเงินท่ีต้องรายงาน ดงันี ้ (1) อตัราสว่นหนีส้ินสทุธิตอ่ก าไรก่อนดอกเบีย้จา่ย ภาษีเงินได้คา่เส่ือมราคา และคา่ตดัจ าหนา่ย (net debt to EBITDA ratio) (2) อตัราสว่น
3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
Coefficient of variation = Standard deviation/Mean, higher the coefficient of variation, higher the variability in the data Note: IVL NAM Spreads over raw material based on 100% PET integration from Ethane
Clause 5 throughout any calendar year, such licensee shall pay the minimum fee as specified under Paragraph 1 without the obligation to pay the fee based on business volume. Clause 7 4 A securities
under Paragraph 1 of Clause 5 throughout any calendar year, such licensee shall pay the minimum fee as specified under Paragraph 1 without the obligation to pay the fee based on business volume. Clause 74
Baht 152 million; an increase of Baht 115 million in terms of loss compared to 2018, which had a net loss of Baht 37 million. In line with contractual obligation, the company was obliged to deliver the